These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 10222005

  • 1. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD, Zackert WE, Yang JP, Kurhts EH, Callewaert D, Dworski R, Kanai K, Taber D, Moore K, Oates JA, Roberts LJ.
    Anal Biochem; 1999 May 01; 269(2):326-31. PubMed ID: 10222005
    [Abstract] [Full Text] [Related]

  • 2. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
    Davies SS, Zackert W, Luo Y, Cunningham CC, Frisard M, Roberts LJ.
    Anal Biochem; 2006 Jan 15; 348(2):185-91. PubMed ID: 16309621
    [Abstract] [Full Text] [Related]

  • 3. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
    Morales CR, Terry ES, Zackert WE, Montine TJ, Morrow JD.
    Clin Chim Acta; 2001 Dec 15; 314(1-2):93-9. PubMed ID: 11718683
    [Abstract] [Full Text] [Related]

  • 4. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
    Nourooz-Zadeh J, Cooper MB, Ziegler D, Betteridge DJ.
    Biochem Biophys Res Commun; 2005 May 13; 330(3):731-6. PubMed ID: 15809058
    [Abstract] [Full Text] [Related]

  • 5. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
    Dworski R, Roberts LJ, Murray JJ, Morrow JD, Hartert TV, Sheller JR.
    Clin Exp Allergy; 2001 Mar 13; 31(3):387-90. PubMed ID: 11260149
    [Abstract] [Full Text] [Related]

  • 6. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
    Schwedhelm E, Tsikas D, Durand T, Gutzki FM, Guy A, Rossi JC, Frölich JC.
    J Chromatogr B Biomed Sci Appl; 2000 Jul 07; 744(1):99-112. PubMed ID: 10985571
    [Abstract] [Full Text] [Related]

  • 7. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA, Croft KD, Puddey IB, Beilin LJ.
    Anal Biochem; 1999 Mar 01; 268(1):117-25. PubMed ID: 10036170
    [Abstract] [Full Text] [Related]

  • 8. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H, Watzer B, Seyberth HW, Nüsing RM.
    J Mass Spectrom; 1997 Dec 01; 32(12):1362-70. PubMed ID: 9423285
    [Abstract] [Full Text] [Related]

  • 9. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
    Mas E, Michel F, Guy A, Bultel V, Falquet Y, Chardon P, Rossi JC, Cristol JP, Durand T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep 01; 872(1-2):133-40. PubMed ID: 18706873
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
    Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH.
    Circulation; 2004 Feb 24; 109(7):843-8. PubMed ID: 14757688
    [Abstract] [Full Text] [Related]

  • 12. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
    Marlière S, Cracowski JL, Hakim A, Stanke-Labesque F, Hoffmann P, Bessard G.
    Can J Physiol Pharmacol; 2005 Jun 24; 83(6):453-8. PubMed ID: 16049544
    [Abstract] [Full Text] [Related]

  • 13. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography.
    Tsikas D, Suchy MT.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr 15; 1019():191-201. PubMed ID: 25583542
    [Abstract] [Full Text] [Related]

  • 14. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane.
    Il'yasova D, Morrow JD, Ivanova A, Wagenknecht LE.
    Ann Epidemiol; 2004 Nov 15; 14(10):793-7. PubMed ID: 15519902
    [Abstract] [Full Text] [Related]

  • 15. F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans.
    Helmersson J, Basu S.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Aug 15; 65(2):99-102. PubMed ID: 11545626
    [Abstract] [Full Text] [Related]

  • 16. Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats.
    Tong V, Teng XW, Karagiozov S, Chang TK, Abbott FS.
    Free Radic Biol Med; 2005 Jun 01; 38(11):1471-83. PubMed ID: 15890621
    [Abstract] [Full Text] [Related]

  • 17. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
    Bachi A, Brambilla R, Fanelli R, Bianchi R, Zuccato E, Chiabrando C.
    Br J Pharmacol; 1997 Aug 01; 121(8):1770-4. PubMed ID: 9283716
    [Abstract] [Full Text] [Related]

  • 18. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
    Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB.
    Anal Biochem; 1999 Aug 01; 272(2):209-15. PubMed ID: 10415090
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations.
    Wu P, Roberts LJ, Shintani AK, Sheller JR, Minton PA, Higgins SB, Hartert TV.
    Free Radic Res; 2007 Sep 01; 41(9):956-62. PubMed ID: 17729112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.